(Total Views: 316)
Posted On: 03/09/2022 9:55:55 AM
Post# of 117

$ACAD News Article - Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID (pimavanserin) for the Treatment of Alzheimer's Disease Psychosis https://marketwirenews.com/news-releases/acad...33280.html


My Twitter: WhyteStocks